Silence Therapeutics plc Share Price
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
12:40:12 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 14.79 USD | +0.34% |
|
+9.16% | +142.93% |
| Market Cap | 66Cr 89Cr 76Cr 72Cr 122.62Cr 8.37TCr 123.54Cr 852.45Cr 330.83Cr 4.28TCr 332.7Cr 325.43Cr 14TCr | P/E 2026 * |
-21.8x | P/E 2027 * | -18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 52Cr 71Cr 61Cr 57Cr 98Cr 6.67TCr 98Cr 679.51Cr 263.71Cr 3.41TCr 265.21Cr 259.41Cr 11TCr | EV / Sales 2026 * |
1,610x | EV / Sales 2027 * | 642x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Silence Therapeutics plc
| 1 day | +0.31% | ||
| 1 week | +9.16% | ||
| Current month | +9.16% | ||
| 1 month | +38.30% | ||
| 3 months | +131.87% | ||
| 6 months | +146.99% | ||
| Current year | +142.93% |
| 1 week | 13.09 |  | 15.28 |
| 1 month | 10.32 | | 17.58 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/07/26 | Sell | 8,65,112 | 0.6105% | |||
| 02/01/26 | Free | Chief Financial Officer | 3,75,000 | 0.2646% | ||
| 02/01/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | +9.16% | +209.64% | +71.94% | 89Cr | |
| +0.97% | -0.75% | +3.51% | +17.79% | 4.97TCr | |
| +0.03% | -2.73% | +430.10% | +521.99% | 4.5TCr | |
| +2.78% | +1.48% | +44.43% | +20.14% | 4.25TCr | |
| +0.89% | -3.74% | +8.95% | +76.61% | 4.08TCr | |
| -0.90% | -1.74% | +15.20% | +48.44% | 3.29TCr | |
| +2.20% | +6.19% | - | - | 1.71TCr | |
| +1.49% | -4.51% | +24.89% | +123.00% | 1.63TCr | |
| +1.70% | -0.05% | +18.53% | +28.09% | 1.44TCr | |
| +2.69% | -1.83% | +79.65% | +41.80% | 1.35TCr | |
| Average | +1.17% | -1.40% | +92.77% | +105.53% | 2.73TCr | |
| Weighted average by Cap. | +1.05% | -2.22% | +94.58% | +128.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 4L 4L 4L 6L 4.14Cr 6L 42.2L 16.38L 2.12Cr 16.47L 16.11L 6.96Cr | 8L 10.14L 9L 8L 14.03L 9.58Cr 14.13L 97.52L 37.85L 4.9Cr 38.06L 37.23L 16Cr |
| Net income | -4.14Cr -5.6Cr -4.83Cr -4.55Cr -7.75Cr -528.8Cr -7.81Cr -54Cr -21Cr -270.36Cr -21Cr -21Cr -888.12Cr | -6.63Cr -8.95Cr -7.72Cr -7.27Cr -12Cr -845.61Cr -12Cr -86Cr -33Cr -432.33Cr -34Cr -33Cr -1.42TCr |
| Net Debt | -13Cr -18Cr -16Cr -15Cr -25Cr -1.7TCr -25Cr -172.94Cr -67Cr -868.12Cr -67Cr -66Cr -2.85TCr | -17Cr -24Cr -20Cr -19Cr -33Cr -2.22TCr -33Cr -226.15Cr -88Cr -1.14TCr -88Cr -86Cr -3.73TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $14.78 | +0.27% | 4,02,002 |
| 01/26/01 | $14.74 | +8.94% | 11,34,889 |
| 31/26/31 | $13.53 | +0.82% | 4,78,194 |
| 28/26/28 | $13.42 | -0.22% | 5,39,704 |
| 27/26/27 | $13.45 | -0.59% | 2,83,674 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
